Trial Profile
A Phase I, Single Center, Open Label, Two Groups Study to Assess the Safety and Pharmacokinetics of Ceftaroline in Healthy Chinese Volunteers Following Single and Multiple Administration of 600 mg Ceftaroline Fosamil as 60-minute Intravenous Infusion Every 12 Hours and as 120-minute Intravenous Infusion Every 8 Hours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2017
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Community-acquired pneumonia; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 07 Oct 2015 New trial record